Anti-Smoking Drug Chantix Recalled Over Cancer Risk

USA Today reports:

Pfizer is voluntarily recalling all lots of its popular anti-smoking drug Chantix for high levels of nitrosamine, which can increase the risk of cancer. According to the notice posted on the Food and Drug Administration website, the recall is for all lots of 0.5 mg and 1 mg varenicline tablets.

The recall notice says that long-term ingestion can lead to a “potential increased cancer risk in humans, but there is no immediate risk to patients taking this medication.”

The FDA said in an update that patients should “continue taking their current medicine until their pharmacist provides a replacement or their doctor prescribes a different treatment.”

Read the full article.

Pfizer Expands Voluntary Nationwide Recall to include All Lots of CHANTIX® (Varenicline) Tablets Due to N-Nitroso Varenicline Content https://t.co/AnwiOx5kgD pic.twitter.com/toSABXbzHK

— U.S. FDA Recalls (@FDArecalls) September 17, 2021